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ABSTRACT: Why do we in the US spend more money on healthcare than anyone else 
in the world but keep getting sicker, fatter, and more susceptible to healthcare shocks 
such as the covid-19 pandemic than anyone else? What is the solution to this problem? In 
this paper, I argue that three causation-correlation errors that we made in the vetting and 
gatekeeping of scientific research findings—as the findings flowed down the healthcare 
hierarchy from scientists to doctors and their patients—landed us in the healthcare 
quagmire. By leveraging the wisdom and power of crowds, we can use three strategies–– 
low-carb, high-dose micronutrients, and cause-based treatments strategies––to obtain 
superior solutions to the problem at little or no cost. These strategies are disruptive to the 
business models of the status quo healthcare players who have presided over the 
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For decades, we have outdone the world in healthcare expenditures only to get 
sicker, fatter, and more susceptible to healthcare shocks such as the covid-19 pandemic 
even as drug makers and other healthcare players have made money year after year. This 
raises two multi-trillion dollar questions. What caused this healthcare quagmire? What is 
the solution to this monumental problem?  
 
THE CAUSES OF THE MASSIVE HEALTHCARE PROBLEM 
Understanding how we got into the healthcare quagmire starts with knowing that, 
in scientific evidence-based medicine, medical doctors usually do not generate the core 
scientific knowledge that they use at work. Medical doctors are usually in the healthcare 
frontlines saving lives, as we witnessed in the covid-19 pandemic. Scientists generate the 
original scientific knowledge about the human body—about the ultimate self-
preservation machine—and the nutrients that the machine must be fed, what should be 
kept out of it, and the causes and cures of the diseases that afflict it (the body). These 
scientists’ findings are vetted by communities of other scientists in a vetting process that 
depends on the incentives and absorptive capacities of the scientists involved. Vetted 
research findings then pass through gatekeepers—e.g., doctors, medical associations, 
drug makers, medical schools, medical journals, food companies, hospitals, government 
agencies, politicians, etc.—who filter, reinterpret, misinterpret, or manipulate the findings 
to reflect their own interests, incentives and absorptive capacities before passing the 
findings (or what is left of them) down the healthcare hierarchy to patients and their 
doctors.  
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For example, if your doctor says you are overweight and should go on a low-fat 
diet, there is a very good chance that he or she did not conduct randomized studies to 
obtain a result showing that overweight people will lose weight by going on a low-fat 
diet. There is a good chance that the information came from government dietary 
guidelines (such as the food pyramid) that reflect the incentives of gatekeepers rather 
than those of the scientists who generated the original scientific knowledge on what we 
should eat or not eat, why and why not. 
In any case, because of imperfections in these vetting and gatekeeping processes, 
decision makers made three major causation-correlation errors about what we should or 
should not eat and what medicines we should take and should not take—mistakes that 
landed us in the healthcare quagmire, and that powerful organizations exploited to build 
very profitable and entrenched business models. What were these three mistakes? 
 
Blaming Dietary Saturated Fats for Heart Disease 
The first causation-correlation error was blaming dietary saturated fat for causing 
heart disease while, importantly, letting the real perpetrator—excessive carb intake—get 
away with murder.1 Doctors, hospitals, and medical associations instructed us to eat low-
fat foods high in carbs, exercise frequently, and stay away from dietary fats, especially 
saturated fats, even as we got sicker and fatter every year despite following these orders. 
Food companies were only too happy to offer low-fat foods loaded with sugar and other 
carbs, actively encouraging people to eat more of these foods and do so frequently. Drug 
makers were more than happy to develop and market drugs to “help” us “manage” or 
prevent the diseases afflicting us, without determining the root causes of the diseases. It 
turns out that carbs are not an essential nutrient––that is, we do not have to consume 
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carbs to live––and therefore eating too many of them is “toxic” to the body. Indeed, 
excessive carb intake causes or exacerbates many nasty diseases including most of the 
top ten killers and a lot more—that is, excessive carb intake is a major contributor to 
making us sicker and fatter.  
 
Failure to Understand the Depth and Breadth of Micronutrient Deficiencies 
The second error that we made in the vetting and gatekeeping processes was in 
not realizing that maiming diseases (e.g., rickets, cretinism/goiter, beriberi, etc.) that were 
caused by micronutrient deficiencies—deficiencies in essential micronutrients (vitamins 
and minerals)—were only the tip of the iceberg of the numerous other diseases that these 
deficiencies can cause or exacerbate. Importantly, these numerous other diseases can be 
prevented, reversed, or managed with higher doses of the micronutrients, not drugs. For 
example, rickets is but the tip of the iceberg of the numerous diseases caused or 
exacerbated by deficiencies in Vitamin D—diseases that can be prevented, reversed or 
managed with high doses of the steroid hormone. Over the years, depleted soils, over-
processed foods, pollution, and our habits have only made these deficiencies more severe 
and widespread. As diseases from the deficiencies have become more rampant and 
severe, drug makers have happily developed and marketed more drugs to treat or prevent 
the diseases, while leaving the root causes of the diseases—micronutrient deficiencies—
to wreak even more havoc on health. 
 
Targeting Measurable Disease-Correlates for Treatment Rather than Pursuing the 
Root Causes of Diseases. 
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The third causation-correlation mistake we made—as a result of the imperfections 
in the vetting and gatekeeping processes in scientific research—was that, as the diseases 
caused or exacerbated by excessive carb intake, hidden micronutrient deficiencies, and 
other factors got more pervasive, drug makers developed even more drugs to prevent or 
cure these diseases and others. However, rather than targeting and eliminating the root 
causes of diseases—e.g., targeting excessive carb intake and hidden micronutrient 
deficiencies—drug makers focused on producing drugs to treat measurable disease-
correlates. (A disease’s correlates are the other diseases or signals/symptoms generated 
by the root cause of the disease.) Treating the correlates of a disease—rather than 
pursuing the root cause of the disease—simply leaves the cause of the disease to keep 
wreaking havoc. For example, research and empirical observation now suggest that high 
blood pressure is a correlate of heart disease, obesity, stroke, and other diseases caused 
by excessive carb intake or severe micronutrient deficiencies (e.g., magnesium, 
potassium, etc. deficiency). Therefore, using drugs to lower high blood pressure hoping 
to reduce heart disease and stroke rarely achieves the goal and leaves the real 
perpetrators—excessive carb intake, deficiencies in micronutrients such as magnesium, 
potassium, etc.—to keep causing or exacerbating heart disease, stroke and more. What is 
even more tragic in using drugs to treat disease-correlates—rather than pursuing the root 
cause of the disease—is that some of the drugs end up creating new health problems, 
requiring even more new drugs. 
Now that we know what caused the massive healthcare problem, the question 




SOLUTIONS TO MONUMENTAL PROBLEMS 
Getting us out of the healthcare quagmire at little or no cost is a monumental 
problem that belongs to a category of problems that appear impossible to solve using 
status quo approaches but become relatively easier to solve using crowds.2 The Longitude 
Problem that was solved back in the 1700s using crowds comes to mind.3 A more recent 
example is Wikipedia whose "problem" of offering the most comprehensive encyclopedia 
to everyone in the world—for free—would be near impossible to solve without the use of 
crowds. In problem solving, a crowd is defined not so much by the number of solvers 
(people solving a problem), but by whether the people solving the problem have been 
designated to solve it or not. In crowdsourcing, solvers self-select to solve the problem 
with no ex ante contracts. For example, the people who write Wikipedia entries are not 
Wikipedia employees or contractors who have been hired by the organization to create 
entries. Rather, these people self-select to write Wikipedia entries without being 
specifically selected by Wikipedia to write specific entries.  
The question is: Why do crowds provide superior solutions to these monumental 
problems—solutions that are superior to the status quo solutions provided by those who 
have traditionally solved similar problems? Crowds often have the incentives, resources 
(skills, time, knowhow, mentality, etc.) and other attributes to solve these problems that 
those who have traditionally solved the problems—status solvers—are not likely to have. 
For example, drug companies, hospitals and other status quo healthcare players are not as 
interested in finding a free non-drug solution to Type 2 diabetes as the patient who has 
been told the disease is incurable and must be managed with drugs (riddled with adverse 
side effects) for the rest of the patient’s shortened life. Crowd’s of patients, loved ones, 
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family members, academics, and others—some of whom are doctors—have the 
incentives and skills to read and interpret the original scientific research showing that a 
low-carb diet (less than 50 grams per day) can be used to reverse Type 2 diabetes. 
With this background information on why solving monumental problems using 
crowds is more likely to deliver superior solutions than solutions from status quo solvers, 
let us move on to the solution to our healthcare quagmire. 
 
THE SOLUTION TO THE HEALTHCARE PROBLEM 
We can solve our massive healthcare problem by using crowds to pursue three 
strategies: Low-carb, high-dose micronutrients, and cause-based treatment strategies. 
 
Low-carb Strategies 
In a low-carb strategy, people use highly restricted carb diets (less than 50 grams 
of carbs a day) to prevent, reverse, or manage the diseases that are caused or exacerbated 
by excessive carbohydrate intake. These diseases/symptoms include acne, attention deficit 
hyperactivity disorder (ADHD), Ancanthosis nigricans, Alzheimer’s disease, asthma, autism, 
cancer (especially breast, colon, ovarian, pancreatic, renal, and aggressive prostate), cataracts, 
chronic obstructive pulmonary disease (COPD), dementia, depression, enlarged prostate, epilepsy, 
erectile dysfunction, fatty livers, gastro-esophageal reflux disease (GERD), glaucoma, gout, heart 
burn, heart disease, high blood pressure, infertility, inflammation, insomnia, insulin resistance, 
kidney disease, macular degeneration, metabolic syndrome, Ménière’s disease, mental fog, 
migraines, non-alcoholic fatty liver, obesity, Parkinson’s disease, polycystic ovary syndrome 
(PCOS), psoriasis, retinopathy, sleep apnea, stroke, spare tire belly, tinnitus, tooth decay, Type 2 
diabetes, vertigo, and many others.4  
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Because no drugs or new products are required, anyone anywhere in the world 
can benefit from low-carb strategies. Low-carb diets include Atkins, ketogenic diet 
(omnivore, vegetarian, or vegan keto), carnivore, and so on. The common denominator in 
these diets is that the total number of carbs consumed a day is below 50 grams. Calories 
matter but only when they are from carbs.  
What do crowds have to do with all this? Everything! To illustrate the role of 
crowds, consider Type 2 diabetes. Prior to the Internet, knowledge of the causes and 
treatment of Type 2 diabetes circulated largely among doctors, hospitals, drug companies, 
medical associations, medical schools, medical journals, medical schools, and other 
healthcare players who acted as gatekeepers of what got to patients. With the advent of 
the Internet, academics from different backgrounds, people with a family history of Type 
2 diabetes, Type 2 diabetics, people who reversed their Type 2 diabetes using a low-carb 
diet, and outer circle doctors exchange information about how to use a low-carb diet to 
reverse Type 2 diabetes—a disease once thought to be incurable. These crowds have the 
resources (emotional support, knowhow, etc.) and incentives (e.g., the need to do good) 
help people in their efforts to prevent or reverse Type 2 diabetes just by changing their 
diet. No drugs. 
 
High-dose Micronutrient Strategies  
While low-carb strategies are about what (and how much) we are consuming that 
we should not be consuming, high-dose micronutrient strategies are about which 
micronutrients (and how much of each) we should be consuming that we are not. The 
strategies are about essential micronutrients—about vitamins and minerals that we need 
to consume to live. In a high-dose micronutrient strategy, people leverage the high-dose 
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potential of life-saving micronutrients (e.g., magnesium, zinc, Vitamin D, iodine, 
Vitamin B1, etc.) to fight diseases beyond the ones that the vitamins and minerals were 
“discovered” to cure. For example, high plasma levels of Vitamin D (from high doses of 
Vitamin D) can prevent, reverse, or control the following diseases/symptoms that are 
caused or exacerbated by Vitamin D deficiency: acute respiratory distress syndrome (ARDS), all-
cause mortality, allergies, arthritis, asthma, autism, autoimmune diseases (e.g., Type 1 diabetes), back pain, 
bone brittleness, bone pain, bowed legs, cancer (especially breast, colon, ovarian, pancreatic, aggressive 
prostate, and renal), cataracts, chronic fatigue, chronic obstructive pulmonary disease (COPD), covid-19, 
depression, diabetes, frequent injuries (especially for athletes), heart disease, hypertension, infertility, 
inflammation, influenza, insulin resistance, knocked knees, kyphosis, leprosy, lordosis, loss of strength 
(e.g., athletes), mental fog, metabolic syndrome, miscarriage, multiple sclerosis, muscle pain, muscle 
spasm, osteomalacia, pre- and post-natal issues, rickets, scoliosis, skin issues, stroke, tuberculosis, Type 2 
diabetes, and many others.5   
Billions of people worldwide who suffer from these hidden deficiencies could 
benefit from high-dose micronutrient strategies. No new products. Only a clever increase 
in the dosage of micronutrients—the same micronutrients that have nourished our bodies 
for thousands of years—is needed. The word “micronutrients” is emphasized here 
because the high doses in question are doses of micronutrients, and NOT of synthetic 
chemical compounds with side effects—not synthetic chemical compounds such as those 
produced by drug makers and often approved by government institutions such as the 
Food and Drug Administration (FDA) in the US and prescribed by doctors and other 
healthcare professionals.  
What do crowds have to do with high-dose micronutrients as a solution to the 
healthcare quagmire? Everything. To see how, consider Vitamin D. First, some online 
websites are dedicated to Vitamin research and its numerous benefits beyond curing 
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rickets. Second, many people share their Vitamin D stories with trusted others on social 
media, and the word goes around.   
 
Cause-Based Treatment Strategies 
The third strategies for delivering superior healthcare solutions at very low cost—
thereby contributing to getting us out of the healthcare quagmire—are the cause-based 
treatment strategies. In cause-based treatment strategies, consumers work with their 
doctors to ensure that each treatment (drug, procedure, etc.) that they are prescribed for a 
disease goes to the root cause of the disease rather than to silencing measurable disease-
correlates/symptoms from the root cause of the diseases. Two examples illustrate this.  
First, if someone has high blood pressure, it is important to determine the root 
cause of the high blood pressure. High blood pressure may be caused by micronutrient 
deficiencies (e.g., deficiencies in magnesium, potassium, Vitamin D, vitamin C, etc.), 
excessive carb intake, or something else—the same perpetrators that also cause heart 
disease, stroke, and other diseases. Using drugs (e.g. diuretics) to make the high blood 
pressure go away may not only be useless in treating the diseases caused by the 
micronutrient deficiency or excessive carb intake but the drugs may also create new 
health problems of their own. Other measures taken to lower blood pressure (in the name 
of preventing heart disease and stroke) can be just as ill-advised. For example, telling 
people to keep their salt intake low to avoid high blood pressure may actually end up 
doing the opposite of what is intended: Increasing the risk of death from heart failure by 
as much as 160%.6 This is not surprising to those who have read the original scientific 
literature showing that we need to consume sodium and chloride—the two elements that 
make up salt—to live. Sodium and chloride are essential nutrients. Also, because many 
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people get iodine (another essential mineral) from iodine-fortified salt, cutting back on 
salt can mean iodine deficiency for some people, especially in developing countries.  
Second, because cholesterol is often found in the plaque buildup in the arteries of 
heart disease victims, cholesterol-reducing drugs (e.g., statins) have been prescribed to 
reduce total plasma cholesterol levels hoping to stem heart disease. Decades of using 
statins to “normalize” plasma cholesterol levels have done little to prevent heart disease 
from maintaining its position as the number one killer in the United States. What is even 
more disheartening is that statins have very nasty side effects. These nasty side effects 
should not surprise those who know that the body is a lot smarter than us and produces 
cholesterol everyday because it needs the substance to perform at least five vital 
physiological functions. Statins inhibit the body’s ability to produce this important 
substance, thereby inhibiting the body’s ability to do what it has done for thousands of 
years to help us thrive. The point here is that we have to be careful with drugs that 
second-guess the ultimate self-preservation machine that is the human body—the 
machine that keeps us and our offspring healthy, and that has worked relatively well for 
thousands of years. Our bodies know more than we do. 
Effectively, if patients and their doctors (as patients’ agents, not distributors for 
drug firms) choose only drugs that treat the root causes of diseases, pharmaceutical 
companies may develop such treatments rather than silencing measurable disease-
correlates while leaving the root causes of diseases to keep wreaking havoc. The ultimate 
goal of cause-based treatment strategies is to avoid drugs that add little or no value to 
preventing, curing, or reversing diseases and yet cause new health problems. What do 
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crowds have to do with all this? Crowds can help patients get to the root causes of 
diseases. 
In summary, the potential of the three strategies—low-carb, high-dose 
micronutrients, and cause-based treatment—to deliver superior solutions to consumers’ 
health problems at low cost is phenomenal. Pursuing the strategies can prevent, reverse, 
treat or manage many nasty diseases—including most of the top ten killers—while 
trimming trillions of dollars off healthcare costs. Restriction of carb intake, elimination of 
some drugs, and the use of high-dose micronutrients are the primary focus. The question 
is: If these strategies are that good, why haven’t they already been used to stop us from 
getting sicker and fatter every year, taking us out of the healthcare quagmire?  
 
BARRIERS TO THE PURSUIT OF THE STRATEGIES  
There are four major barriers to the pursuit and success of the three strategies: 
Money, beliefs, habits, and competitive advantage.  
 
Money 
 The three strategies are disruptive to the business models of incredibly powerful 
healthcare players that include inner circle status quo doctors, hospitals, pharmaceutical 
companies, medical associations, medical schools, politicians, insurance companies, 
pharmaceutical benefits managers, and so on. This business model disruption means less 
money for these players and, therefore, they have sought to defend their business models 




Patients’ beliefs and trust in doctors—the doctors who believe in the status quo solutions 
that are being disrupted by the three strategies—can make it difficult for the patients to 
take advantage of the three disruptive strategies. These beliefs include believing that one 
knows better than the human body. Worse still, doctors’ beliefs in status quo solutions—
e.g., using drugs to treat nutritional deficiencies or measurable disease-correlates—can be 
very difficult to change. 
 
Habits 
Carbs can be as addictive as alcohol—which is made from carbs—making it 
difficult for some people to follow a low-carb strategy. Just as unfortunate, some 
prescription drugs can be addictive to patients, making it difficult for them to get off 
drugs that cause more harm than good. 
 
Competitive advantage.  
A person’s competitive advantage is something that enables the person to 
outperform his or her perceived rivals. Some people just have to win at whatever they do 
and, therefore, need something to give them that edge to win. Whether it is in losing 
weight, beating diabetes, having better medical exam reports, having a flat tommy, or 
looking good, these people want to win. Low-carb, high-dose micronutrient, and cause-
based strategies are that something—that competitive advantage—that helps these people 
win. Some very competitive people tend to keep these competitive advantages a secret. 
This is particularly true of high-dose micronutrient strategies—e.g., high-dose Vitamin D 





OVERCOMING THE BARRIERS 
Fortunately, as formidable as these barriers appear to be, three factors are 
enabling anyone from anywhere in the world to overcome the barriers to successfully 
pursuing the three strategies. First, using digital technologies, people can leverage the 
power and wisdom of crowds to bypass healthcare gatekeepers—doctors, drug makers, 
medical associations, medical schools, hospitals, governments, etc.—to obtain 
information about diseases, their causes, and cures directly from well-vetted original 
scientific sources, rather than depending on these gatekeepers that filter and manipulate 
information to reflect their interests and incentives. Bypassing these gatekeepers 
drastically reduces their power over patients, thereby erasing some of the major hurdles 
to the three strategies.  
The second factor that is enabling anyone anywhere to overcome the barriers is 
the fact that many powerful people in the healthcare value chain—doctors, heads of 
medical schools, medical journal editors, heads of medical associations, heads of 
hospitals, healthcare activists, and numerous other powerful healthcare professionals and 
executives—are succumbing to Type 2 diabetes, obesity, spare tire bellies, covid-19, or 
some of the numerous other diseases/symptoms caused or exacerbated by excessive carb 
intake, micronutrient deficiencies, and drugs targeting measurable disease-correlates 
rather than the root causes of diseases. These powerful people are becoming increasingly 
aware that status quo solutions will not work for them and their loved ones.  
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For example, doctors who have become type 2 diabetics are not likely to stick 
with the status quo of taking drugs and eventually going blind, succumbing to heart 
disease, kidney disease. or getting their limbs amputated when all they have to do is 
pursue a low-carb strategy that comes with numerous other health benefits. That is, these 
very powerful people are not likely to refuse low-carb strategies in favor of impotent 
status quo solutions that—for example—see type 2 diabetes as an incurable disease. Even 
the American Diabetes Association came to grips with the reality of low-carb strategies 
when, in May 2019, its Diabetes Care publication said, “Reducing overall carbohydrate 
intake for individuals with diabetes has demonstrated the most evidence for improving 
glycemia and may be applied in a variety of eating patterns that meet individual needs 
and preferences.”8 
The third factor helping people overcome the barriers to the three strategies is the 
covid-19 pandemic and its negative impact on the health and economies of the world. 
The need to solve such an urgent problem—and the irrelevance of status quo solutions—
has given the strategies more teeth to overcome the barriers confronting them. For 
example, knowing that high doses of Vitamin D are the solution to the covid-19 problem 
is a strong incentive to pursue high-dose micronutrient strategies rather than status quo 
solutions.9 Also, knowing that most victims of convid-19 complications tend to be those 
with pre-existing health conditions—caused or exacerbated by excessive carb intake, 





Can the three strategies solve the covid-19 pandemic problem? Yes, they can!10 
Research suggests that high serum levels of Vitamin D—from high doses of Vitamin D—
significantly reduce infections and deaths from covid-19. Zinc, iodine, and Vitamin C are 
also being investigated for their antiviral “vaccine-like” immune properties—properties 
that can fight the virus and its damaging effects. Also, early analysis of the data from the 
pandemic showed that more than 90% of the most vulnerable patients to severe 
complications from covid-19 suffered from pre-existing health conditions such as 
obesity, heart disease, high blood pressure, diabetes, stroke, chronic lower respiratory 
disease, cancer, and spare tire belly.11 These diseases are a subset of the diseases that 
low-carb strategies can prevent, reverse or fight. Also, it has been hypothesized that some 
of the drugs used to treat measurable disease-correlates might be problematic in the face 
of covid-19. Effectively, in addition to doing what healthcare professionals and 
authorities tell us to do—e.g., social distancing, wearing masks, frequent and thorough 
washing of hands, frequent testing, etc.—it may be prudent for us to also pursue the low-
carb, high-dose micronutrient, and cause-based strategies of this paper in the fight against 
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